The FDA approval of denileukin diftitox (Lymphir) marked a significant shift in this paradigm. As a first-in-class immunotoxin, it employs a dual-action mechanism: directly targeting interleukin-2 (IL ...

Can Australia's small cap stocks build on a strong showing in 2025 and positive earnings growth to make next year one to ...

In his capacity of assistant, the writer directed the investigation of the grade-placement of addition and subtraction of fractions.2 Upon further study and analysis the method of interpreting the ...

Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...

Listening to the news can feel like a journey. But 1A guides you beyond the headlines – and cuts through the noise. Let's get to the heart of the story, together – on 1A.